Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
about
Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMPPalmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common ColdPD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell responseCritical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infectionModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsVitamin D and influenzaAcute respiratory distress syndrome induced by a swine 2009 H1N1 variant in miceInfluenza Virus Targets Class I MHC-Educated NK Cells for ImmunoevasionInflammatory cytokine expression is associated with chikungunya virus resolution and symptom severityLong term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipientsTwo years after pandemic influenza A/2009/H1N1: what have we learned?Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemicLow titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.Pulmonary immune responses to 2009 pandemic influenza A (H1N1) virus in mice.Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection.Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung.Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines.Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1.Cytokine profiles of suction pulmonary secretions from children infected with pandemic influenza A(H1N1) 2009Host response to influenza virus: protection versus immunopathology.Host adaptive immunity deficiency in severe pandemic influenza.Severe pandemic (H1N1)v influenza A infection: report on the first deaths in Spain.Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patientsClinical aspects and cytokine response in severe H1N1 influenza A virus infectionDevelopment of adenoviral vector-based mucosal vaccine against influenza.Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection.The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation.The impact of sex, gender and pregnancy on 2009 H1N1 diseaseProinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.Comparison of pandemic (H1N1) 2009 and seasonal influenza viral loads, Singapore.Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection.Novel influenza A (H1N1) infection vs. common influenza-like illness: a prospective studyPandemic 2009 H1N1 virus infection associated with purpuric skin lesions: a case reportInfluenza 2009 pandemic: Cellular immunemediated surveillance modulated by TH17 & Tregs.The first influenza pandemic of the new millennium.Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection.Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivoSuppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.
P2860
Q21090975-CE352D3E-0A5F-4060-8428-DE81B16A98AAQ21285123-D8D3B1D9-AA5F-4F57-B626-6D5ACB26159FQ24339361-1004E88D-906A-4521-8180-9FB4DCE57B86Q24629018-9AEBACC7-D2E6-4854-B4E9-3FDF607673DBQ26800158-B5404934-A07A-424E-8B31-1E9625F205CEQ26830578-CC2FC17A-E1BD-4883-93EE-D939F1AD5CE8Q27310762-6D55381C-F6E9-4B56-B0B4-20627965207BQ27315823-6A21B84C-6737-4F8D-9268-A0F8B32A60AEQ28476579-C06CF7BF-6343-499A-BB12-3414F861F253Q28741451-58E2513B-9CAA-4A67-B60B-01F01A9C9D53Q30224656-5473DD6C-98F2-4C47-B68C-CA743EFC5484Q30352743-B577479F-827B-4C69-AA54-871BA7E06ABDQ30360402-AE442DAD-3014-42A0-B596-722A33A5B260Q30361309-0A396069-56C8-4AA0-BFA9-791811A48D06Q30361318-9A355355-A17A-42F2-9798-2509F462902CQ30366138-4B2D39AB-2CE9-43C0-BC57-8A14D113FFF4Q30367153-D086856F-33F6-4E4C-96E7-9569FF3BA46EQ30381864-F9AEF8FE-24AF-4F1E-8920-CF4F48553933Q30386775-415407E7-CBA7-4511-BC65-DBE1F1A7564FQ30388494-F6E9CF49-0A57-45A7-B315-35CB0D7BB447Q30391010-AD90CEB4-E8B3-4AB0-89BA-607DD5088819Q30393612-D5219A5B-556B-427A-96E5-7CCED8FDF6A5Q30394861-F1162F36-024B-40D0-B821-1161CF7AD289Q30395003-4605E05B-B518-4A59-86A4-1CB7DA532EBCQ30396035-16523BD9-039B-4DA6-AC87-11488E965DF5Q30396642-1D7C666A-70BD-4C5A-B1B4-3DE885AB79EFQ30396672-228395FF-37E6-47B3-8205-AD311184E608Q30396915-71CBDB52-EB9B-4103-A9E8-14D3E53E17BAQ30398193-D2DD14E5-6751-4BD1-A78C-8BEA91B1E3EDQ30398612-1AD2F1A1-716C-423C-8386-B83EC68C0988Q30399323-ECB40DE2-F7BD-49AE-B893-DE53D641914BQ30399952-CE6C4388-7A47-41A6-907C-21DD84F74905Q30401338-D82608BC-8535-4D91-BF30-B2C0E91848A2Q30401370-A8D1CB1B-27DF-46D1-935B-4CF77AA9E31BQ30401513-CB9DBCE6-783C-431A-8992-68A70336ADA9Q30401658-F6246374-AAA7-4A98-A629-6A47108E5804Q30403278-05135B91-6D55-4C15-9F24-AB9E139487F6Q30403288-BACE05B3-A06D-418F-8E37-C2316317053FQ30404138-AC9E3BDA-CA84-4B3D-96C1-AB5529496D3DQ30404361-3284D2F1-388B-4E84-9D86-4B4CF4A7B6AA
P2860
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.
@ast
Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.
@en
type
label
Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.
@ast
Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.
@en
prefLabel
Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.
@ast
Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.
@en
P2093
P2860
P50
P356
P1433
P1476
Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.
@en
P2093
Alberto Del Castillo
Alberto Leon
Alberto Tenorio-Abreu
Aurora Lietor
Beatriz Villanueva
Carlos Javier López
Carlos Serón
Carmen Hinojosa
Dariela Micheloud
David Banner
P2860
P2888
P356
10.1186/CC8208
P577
2009-12-11T00:00:00Z
P5875
P6179
1012038777